Biotech company Argos Therapeutics Inc. had its lease terminated for space on the N.C. State campus, according to a Form 8-K filed with the Securities and Exchange Commission. In January, the Durham-based company signed a 10-year lease for a 40,000-foot manufacturing space at the Center for Technology & Innovation on...
Read More
Chimerix Inc., a pharmaceutical research company, exceeded Wall Street analysts’ expectations despite reporting a $15.4 million loss in the fourth quarter. Durham-based Chimerix reported a net loss of 32 cents per diluted share, beating analysts’ estimates of a 39 cents loss per diluted share. During the same period in...
Read MoreDouglas Lebda, the founder, chairman and CEO of LendingTree, sold 8,000 shares of stock for more than $420,000, according to a Securities and Exchange Commission filing. Lebda sold the stock in two transactions on Jan. 12 and Jan. 19, at prices of $104.04 and $105.50 per share, according to a Form 4 filed with the SEC. The Jan. 19 filing states Lebda still owns 1,742,036 shares through personal ownership, family trusts, spousal ownership and Lebda Family Holdings LLC. Lebda founded the financial services company in 1996. LendingTree is an online lending exchange that connects consumers with a network of...
Read More
